Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristin Berry

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Gastroenterology|July 30, 2019
Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 ScoresGeorge N Ioannou, Lauren A Beste, Pamela K Green, et al.
Open Forum Infectious Diseases|October 15, 2025
Budget Impact of Adopting Nirmatrelvir-Ritonavir for Treating COVID-19 in a Large Integrated Healthcare SystemDavid P Bui, Denise M Hynes, Edwin Wong, et al.
JAMA Network Open|February 2, 2023
Rates of and Factors Associated With Primary and Booster COVID-19 Vaccine Receipt by US Veterans, December 2020 to June 2022Kristina L Bajema, Mazhgan Rowneki, Kristin Berry, et al.
American Journal of Epidemiology|October 13, 2025
Impact of time zero designation on estimated COVID-19 antiviral effectiveness in observational studiesKristina L Bajema, Lei Yan, Kristin Berry, et al.
Hepatology (Baltimore, Md.)|December 17, 2024
Validation and expansion of Baveno VII criteria for cACLD and CSPH based on liver stiffness and platelet count: Correlation with risk of hepatic decompensation and deathPhilip Vutien, Abbey Barnard Giustini, Nicole J Kim, et al.
Plos Medicine|October 21, 2021
Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort studyGeorge N Ioannou, Jacqueline M Ferguson, Ann M O'Hare, et al.
The Lancet. Infectious Diseases|January 23, 2025
Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation studyKristina L Bajema, Lei Yan, Yuli Li, et al.
Cancer Epidemiology|July 30, 2025
Exposure to outdoor air pollution, wildfires, and cancer survival in the United StatesTrang VoPham, Tianjia Liu, Malia Cortez, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2022
Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. Veterans: target trial emulation studies with one-month and six-month outcomesKristina L Bajema, Kristin Berry, Elani Streja, et al.
Annals of Internal Medicine|June 5, 2023
Effectiveness of COVID-19 Treatment With Nirmatrelvir-Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month OutcomesKristina L Bajema, Kristin Berry, Elani Streja, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Gastroenterology|July 30, 2019
Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 ScoresGeorge N Ioannou, Lauren A Beste, Pamela K Green, et al.
Open Forum Infectious Diseases|October 15, 2025
Budget Impact of Adopting Nirmatrelvir-Ritonavir for Treating COVID-19 in a Large Integrated Healthcare SystemDavid P Bui, Denise M Hynes, Edwin Wong, et al.
JAMA Network Open|February 2, 2023
Rates of and Factors Associated With Primary and Booster COVID-19 Vaccine Receipt by US Veterans, December 2020 to June 2022Kristina L Bajema, Mazhgan Rowneki, Kristin Berry, et al.
American Journal of Epidemiology|October 13, 2025
Impact of time zero designation on estimated COVID-19 antiviral effectiveness in observational studiesKristina L Bajema, Lei Yan, Kristin Berry, et al.
Hepatology (Baltimore, Md.)|December 17, 2024
Validation and expansion of Baveno VII criteria for cACLD and CSPH based on liver stiffness and platelet count: Correlation with risk of hepatic decompensation and deathPhilip Vutien, Abbey Barnard Giustini, Nicole J Kim, et al.
Plos Medicine|October 21, 2021
Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort studyGeorge N Ioannou, Jacqueline M Ferguson, Ann M O'Hare, et al.
The Lancet. Infectious Diseases|January 23, 2025
Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation studyKristina L Bajema, Lei Yan, Yuli Li, et al.
Cancer Epidemiology|July 30, 2025
Exposure to outdoor air pollution, wildfires, and cancer survival in the United StatesTrang VoPham, Tianjia Liu, Malia Cortez, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2022
Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. Veterans: target trial emulation studies with one-month and six-month outcomesKristina L Bajema, Kristin Berry, Elani Streja, et al.
Annals of Internal Medicine|June 5, 2023
Effectiveness of COVID-19 Treatment With Nirmatrelvir-Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month OutcomesKristina L Bajema, Kristin Berry, Elani Streja, et al.
Pageof 8